The conflict involving Iran has disrupted traffic through the Strait of Hormuz, one of the world’s busiest shipping lanes, creating rising risks for the global pharmaceutical supply chain.
Why this matters
– The U.S. sources nearly half of its generic prescriptions from India. Many Indian manufacturers route shipments through the Strait of Hormuz and also import oil-derived and petrochemical feedstocks—solvents, coatings, plastics, packaging, IV bags and syringes—needed for drug production and medical supplies.
– Attacks and blockades have closed or slowed shipping and damaged petrochemical facilities. Logistics experts note that once traffic resumes, clearing backlogs takes longer than the stoppage itself (about 1.5 weeks to clear one week of halted traffic), so delays can cascade for months.
What has already been observed
– Indian exports fell sharply—roughly a 25% decline in March, according to reported sources cited by medical experts.
– Damage to petrochemical production and interrupted oil flows can constrain raw materials and push up costs for drug manufacturers and makers of packaging and supplies.
Expert assessment
Medical experts say full-scale shortages have not yet occurred, but if disruptions persist they expect some scarcities within a few months. Two groups of products are particularly vulnerable:
1) High-volume generics manufactured in large batches and shipped by sea, which are sensitive to shipping delays.
2) Temperature-sensitive products that rely on air freight and cold-chain handling through regional air hubs (for example, Dubai, Abu Dhabi and Doha); airport closures and rerouting slow delivery and increase costs.
Medications and supplies most at risk
– High-volume generics: widely used off‑patent drugs such as many blood‑pressure medicines, statins, metformin for diabetes, and commonly prescribed antibiotics (for example, amoxicillin) are at higher risk because they are produced in bulk and typically moved by sea.
– Temperature‑sensitive medicines: insulin, certain chemotherapy drugs, and some vaccines require refrigerated transport and dependable air hubs; disruptions to air cargo and cold-chain logistics can delay supply and raise prices.
– Medical supplies: shortages or price increases for plastics, IV bags, syringes and related components can affect both administration and manufacture of drugs and care supplies.
Other consequences
– Helium supply: attacks that affected facilities such as Qatar’s Ras Laffan LNG site—an important helium source used for cooling MRI machines—plus transport disruptions via the Strait threaten helium availability and could raise costs or limit MRI access.
– Clinical trials: overseas trials can be delayed by transport problems and regulatory or logistical hurdles, slowing new-drug development or interrupting ongoing studies.
Practical advice for patients
– Pharmacies typically hold 30–60 days’ supply. If you depend on routine medications, check your prescriptions and consider refilling earlier than usual when possible.
– Do not change or stop medications without medical guidance. If supplies become constrained, talk with your clinician or pharmacist about safe alternatives and contingency plans.
Bottom line
No widespread shortages have been declared yet, but the risk is increasing because of disrupted shipping, damaged petrochemical capacity and strained air routes. Ongoing monitoring by manufacturers and regulators, early refills where appropriate, and coordination with healthcare providers can reduce short‑term patient risk while the supply chain adjusts.